472P Homologous-recombination deficiency (HRD) in gastroesophageal adenocarcinoma (GEA): Clinical and molecular features von Acosta Eyzaguirre, D., Castillo, G., Aguilar Izquierdo, S., Cruellas Lapena, M., Herencia Ropero, A., Landolfi, S., Palma, H., Tian, T., Vivancos, A., Serra Elizalde, V., Macarulla Mercade, T.

Volltext

Experience with eribulin in patients with metastatic breast cancer and associated hepatic impairment: case studies von Acosta-Eyzaguirre, Daniel, Calvo Plaza, Isabel, Perelló Martorell, Antonia, Hernández Agudo, Elena, García-Estévez, Laura

Volltext

Synthesis and Characterization of Core@shell Β-NaYF4 to Yb3+/Ho3+@SiO2 with Different Ratios of Fluorine to Yttrium von Rondan, W., Rivera, M., Acosta, D., Puga, R., Loro, H., Eyzaguirre, C., Champi, A.

Volltext

1223P First-line lenvatinib (Len) + pembrolizumab (Pembro) + chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in von Shitara, K., Ben-Aharon, I., Rojas, C., Acosta Eyzaguirre, D.A., Hubert, A., Araya Moya, H., Cohen, D., Bai, L-Y., Ghiringhelli, F., Wyrwicz, L., Janjigian, Y.Y., Tabernero, J., Van Cutsem, E., Qin, S., Xu, J., Wang, A., Miller, M.G., Shih, C-S., Bhagia, P., Yanez Weber, P.E.

Volltext

426P Spotlight on refractory metastatic colorectal cancer (refMCRC): Role of prognostic characteristics in the continuum of care von Valdivia, A.A., Salva, F., Ros, J., Baraibar, I., Argiles Martinez, G., Saoudi Gonzalez, N., Garcia, A., Mulet Margalef, N., Cuadra Urteaga, J.L., Capdevila, J., Salud Salvia, M.A., Paez, D., Casado, E., Comas, R., Ruiz-Pace, F., Villacampa Javierre, G., Acosta Eyzaguirre, D.A., Dienstmann, R., Elez Fernandez, M.E., Tabernero, J.

Volltext